ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 1206

$475K Total Retail Price of All Prescriptions

Rank: 188 out of 1206

317 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,752 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 533 434 1 2
OMEPRAZOLE 443 399 2 3
PRAVASTATIN SODIUM 432 342 3 21
CITALOPRAM HBR 299 244 4 16
TRIAMTERENE-HCTZ 261 193 5 33
ZOLPIDEM TARTRATE 246 194 6 25
LISINOPRIL 246 191 6 4
LOSARTAN POTASSIUM 244 211 8 20
HYDROCODONE-ACETAMINOPHEN 240 188 S3 9 7
ALENDRONATE SODIUM 195 161 10 19
FUROSEMIDE 187 157 11 5
TAMSULOSIN HCL 179 142 12 26
LOSARTAN-HYDROCHLOROTHIAZIDE 175 170 13 60
DONEPEZIL HCL 170 153 14 29
METFORMIN HCL ER 168 133 15 58
FENOFIBRATE 163 123 16 56
AMLODIPINE BESYLATE 161 157 17 6
ATORVASTATIN CALCIUM 161 146 17 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 129 19 27
POLYETHYLENE GLYCOL 3350 151 126 20 31
MELOXICAM 132 92 21 35
ATENOLOL 126 125 22 14
TRAMADOL HCL 126 96 22 17
TRAZODONE HCL 109 37 24 37
SERTRALINE HCL 104 77 25 22
VERAPAMIL ER 99 89 26 97
MIRTAZAPINE 97 94 27 50
HYDROCHLOROTHIAZIDE 94 65 28 11
TRIAMTERENE-HYDROCHLOROTHIAZID 91 63 29 131
WARFARIN SODIUM 90 84 30 8
METFORMIN HCL 80 40 31 10
BUPROPION XL 80 50 31 151
CARBIDOPA-LEVODOPA 77 77 33 70
FLUOXETINE HCL 74 44 34 52
CRESTOR 70 49 35 30
NABUMETONE 70 61 35 91
ACTOS 70 55 35 98
METOPROLOL TARTRATE 69 69 38 9
METHOCARBAMOL 67 51 R 39 185
OXYBUTYNIN CHLORIDE 65 54 40 68
ALLOPURINOL 65 57 40 24
ROPINIROLE HCL 61 55 42 77
PREDNISONE 60 49 43 28
VENLAFAXINE HCL ER 58 13 44 89
PREMARIN 57 0 R 45 147
RISPERIDONE 56 52 46 74
GLIPIZIDE ER 56 48 46 99
FLUTICASONE PROPIONATE 55 41 48 42
GLIPIZIDE XL 54 54 49 145
SIMVASTATIN 52 43 50 1
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.